Earnings per Share (EPS) is predicted to be $1.06, with a recent estimate suggesting a decrease to $0.97.
Revenue is expected to increase by 9.3% year-over-year to $1.38 billion.
The company's price-to-earnings (P/E) ratio stands at 57.83, indicating investor valuation of...
Snap Inc. (NYSE:SNAP) has received a price target of $12 from RBC Capital, indicating a potential increase of approximately 53.26%.
The company reported a 14% increase in Q1 revenueto $1.36 billion, surpassing estimates, despite challenges in advertising revenue.
Snap's daily active...
Earnings Expectations: Analysts predict an earnings per share of $2.34 and revenue of approximately $791.85 million.
Financial Health Indicators: Matson showcases a P/E ratio of 7.65 and a price-to-sales ratio of 1.06, indicating a balanced market valuation.
Investor Insights: With an...
Ero Copper Corp. (NYSE:ERO) is set to release its quarterly earnings on May 5, 2025, with an anticipated EPS of $0.19.
The company's revenue for the quarter ending March 2025 is projected to be approximately $178.5 million.
Financial metrics reveal a...
Earnings Per Share (EPS) of -$0.05significantly outperformed the estimated EPS, indicating better expense management.
Revenue growth to $44.3 million, surpassing estimates and suggesting increasing sales.
Negative Price-to-Earnings (P/E) ratio of -15.60 and a high enterprise value to operating cash flow ratio...
The consensus price target for Exxon Mobil Corporation (NYSE:XOM) has shown a slight upward trend, indicating modest positive sentiment among analysts.
Exxon Mobil's recent earnings surpassed Wall Street's expectations, driven by increased production, though profits declined due to weaker oil...
The consensus price target for Protara Therapeutics, Inc. (NASDAQ:TARA) has remained stable at $12 over the past year.
Protara has been upgraded to a Zacks Rank #2 (Buy), indicating increased optimism about the company's earnings potential.
Investors are encouraged to stay...
The consensus price target for Criteo S.A. (NASDAQ:CRTO) has decreased from $52.44 to $46, reflecting a more cautious outlook from analysts.
Criteo's stock has declined by 21.15% over the past four weeks, indicating it may be in oversold territory.
Despite recent...
MiMedx Group, Inc. (NASDAQ:MDXG) is a leading company in the advanced wound care and therapeutic biologics sector, specializing in products derived from human placental tissue for various medical applications. The company competes in a challenging landscape against firms like...
BankFinancial Corporation (NASDAQ:BFIN) has a ROIC of 1.96% and a WACC of 4.75%, indicating inefficiencies in capital utilization with a ROIC to WACC ratio of 0.41.
ESSA Bancorp (ESSA) demonstrates better capital efficiency with a ROIC of 16.19% and a...